Revolution Medicines Market Sentiment

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD82,600.29+0.04%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Premium

Revolution Medicines Inc

RVMDNASDAQ

Trade with Public

$189.76

1.640.87%

Last update: Oct 9, 4:00 PM

$188.75

0.630.33%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Revolution Medicines Market Sentiment - Benzinga

Revolution Medicines Market Sentiment

Market sentiment signals for Revolution Medicines (RVMD): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 4.8% short float

Options Flow▼ 3.68 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

30 analysts

Options Flow (P/C)

3.68

More puts — Bearish

771 calls · 2,839 puts

Avg Consensus PT

$191

+0.9%

Highest Price Target

$320

+68.6%

Evercore ISI Group

Lowest Price Target

$64

-66.3%

Stifel

Short Interest

4.8%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 8, 2026	RBC Capital	Leonid Timashev—	+36.5%	$251 → $259	Maintained	Outperform
Oct 7, 2026	Truist Securities	Gregory Renza—	+26.5%	$239 → $240	Maintained	Buy
Sep 28, 2026	Brookline Capital	Leah Rush—	+67.6%	$318	Initiate	Buy
Sep 24, 2026	Goldman Sachs	Andrea Newkirk—	+40.7%	$267	Reinstates	Buy
Sep 21, 2026	B of A Securities	Alec Stranahan—	+39.7%	$225 → $265	Maintained	Buy
Sep 10, 2026	Morgan Stanley	Sean Laaman—	+34.4%	$255	Initiate	Overweight
Sep 9, 2026	Stifel	Laura Prendergast—	+21.2%	$215 → $230	Maintained	Buy
Aug 31, 2026	Needham	Ami Fadia—	+44.9%	$240 → $275	Maintained	Buy
Aug 28, 2026	UBS	Michael Yee—	+39.7%	$220 → $265	Maintained	Buy
Aug 28, 2026	Guggenheim	Michael Schmitz—	+44.9%	$240 → $275	Maintained	Buy
Aug 27, 2026	Oppenheimer	Jay Olson—	+37.0%	$230 → $260	Maintained	Outperform
Aug 27, 2026	RBC Capital	Leonid Timashev—	+32.3%	$203 → $251	Maintained	Outperform
Aug 27, 2026	Wedbush	Robert Driscoll—	+18.6%	$201 → $225	Maintained	Outperform
Aug 27, 2026	Truist Securities	Gregory Renza—	+25.9%	$231 → $239	Maintained	Buy
Aug 27, 2026	Evercore ISI Group	Cory Kasimov—	+68.6%	$230 → $320	Maintained	Outperform
Aug 27, 2026	HC Wainwright & Co.	Robert Burns—	+47.6%	$195 → $280	Maintained	Buy
Aug 21, 2026	Bernstein	Jeffrey Walch—	-5.7%	$151 → $179	Maintained	Market Perform
Aug 11, 2026	Truist Securities	Gregory Renza—	+21.7%	$210 → $231	Maintained	Buy
Aug 6, 2026	RBC Capital	Leonid Timashev—	+7.0%	$182 → $203	Maintained	Outperform
Aug 6, 2026	Wedbush	Robert Driscoll—	+5.9%	$192 → $201	Maintained	Outperform
Aug 6, 2026	Evercore ISI Group	Cory Kasimov—	+21.2%	$220 → $230	Maintained	Outperform
Aug 6, 2026	Guggenheim	Michael Schmidt—	+26.5%	$235 → $240	Maintained	Buy
Aug 6, 2026	Needham	Ami Fadia—	+26.5%	$236 → $240	Maintained	Buy
Jul 23, 2026	Wedbush	Robert Driscoll—	+1.2%	$181 → $192	Maintained	Outperform
Jul 20, 2026	Needham	Ami Fadia—	+24.4%	$235 → $236	Maintained	Buy